Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-04

Clinical Trial Update: Postpartum Continuous Glucose Monitoring for Type 2 Diabetes Mellitus Risk Evaluation in Patients With Gestational Diabetes Mellitus: POSTPOD Trial [NA]

View source ↗

Summary

The POSTPOD trial is currently recruiting to evaluate postpartum continuous glucose monitoring for assessing risk of type 2 diabetes in women with a history of …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of California, Los Angeles | Conditions: Gestational Diabetes Mellitus in Pregnancy | NA | Status: RECRUITING